The Good Health Conquest

Concord Biotech Ltd.
  • 0.0 (0)
  • HEALTH & FITNESS
  • UPDATED MONTHLY

Concord Biotech is committed to helping raise awareness of Lupus, a long term illness that can leave a devastating impact on lives and livelihoods. This podcast series discusses the impact of Lupus with health practitioners, medical experts, caregivers and sufferers to understand how to actively manage this health condition.

  1. 03/05/2024

    Treatment standard for Sepsis-associated acute kidney injury

    Sepsis, a harmful response to infection, can lead to life-threatening organ dysfunction, with sepsis-associated acute kidney injury (SA-AKI) being the most common organ dysfunction and contributing to about 50% of all AKI in critically ill adults. Despite advancements in understanding clinical risk factors, pathobiology, and treatment responses for SA-AKI, it remains a significant health burden. This review explores current treatment standards and novel developments in the pathophysiology, diagnosis, outcome prediction, and management of SA-AKI. Concord Biotech is dedicated to sharing the latest updates on advancements in intensive care. To read more about the article, visit www.incacare.live

    2 min

  2. 03/05/2024

    Management of bacterial and fungal infections in the intensive care unit

    Bacterial and fungal infections pose significant challenges in the intensive care unit (ICU), affecting up to 50% of patients, according to global prevalence surveys. These infections are associated with intrinsic and acquired drug resistance, complicating antimicrobial selection. This comprehensive review explores the diagnosis, management, and prevention of bacterial and fungal infections in the ICU. The analysis delves into current and evolving diagnostic and therapeutic approaches, recognizing the global impact of antimicrobial resistance (AMR). Concord Biotech is dedicated to sharing the latest updates on advancements in intensive care. The Good Health Conquest podcast is available on all major listening platforms and apps. To read more about the article, visit www.incacare.live

    3 min

  3. 01/31/2024

    New Antibiotics for Staphylococcus aureus Infection

    Staphylococcus aureus, a versatile pathogen capable of causing a range of diseases, presents a significant health concern, particularly with its ability to rapidly develop resistance to various antibiotics. The study highlights the historical progression of antibiotic resistance in S. aureus and the subsequent development of new antibiotics. It also explores the characteristics, clinical applications, and potential impact of recently licensed anti-staphylococcal drugs, offering hope in the fight against this pathogen. The Good Health Conquest podcast is available on all major listening platforms and apps. To read more about the article & subscribe to our podcast, log onto www.incacare.live.

    4 min

  4. 01/22/2024

    A Novel Therapeutic Strategy for Aplastic Anemia

    The study focuses on the critical role of the telomerase RNA component (TERC) gene in maintaining telomere length and the implications of its haploinsufficiency in diseases like aplastic anemia (AA). Telomere depletion, associated with cell division and replication, has been linked to the development of AA. The telomerase enzyme, primarily composed of RNA and proteins, is essential for preventing telomere loss. TERC deficiency can disrupt telomerase function, leading to abnormal telomere maintenance, gene transcription issues, and ultimately contributing to diseases such as AA. The study explores the potential of cell reprogramming, a process that transforms cells into pluripotent stem cells, in reversing the differentiation process, enhancing stem cell properties, and extending telomere length. This approach may hold therapeutic promise in mitigating telomere loss and cell aging in the context of Aplastic anemia. Concord Biotech is dedicated to sharing the most recent information regarding renal diseases & complications, rheumatic conditions & hematological disorders.  The Good Health Conquest podcast is available on all major listening platforms and apps. To read more about the article & subscribe to our podcast, log onto www.conquest.health

    3 min

  5. 01/16/2024

    Bacterial Pathogens Causing Pneumonia Post Hematopoietic Stem Cell Transplant

    In allogeneic hematopoietic stem cell transplantation, pulmonary complications are a major cause of morbidity and mortality, with bacterial infections posing persistent challenges. Factors such as immune system alterations, mucosal barrier impairment, and prolonged immunosuppression contribute to the heightened vulnerability of recipients. Concord Biotech is dedicated to sharing the most recent information regarding renal diseases & complications, rheumatic conditions & hematological disorders.  The Good Health Conquest podcast is available on all major listening platforms and apps. To read more about the article & subscribe to our podcast, log onto www.conquest.health.

    3 min

  6. 01/08/2024

    Nebulized Antibiotics in Severe Respiratory Infections

    In the realm of challenging multidrug-resistant pulmonary infections, nebulized antibiotics are gaining prominence for their potential benefits, including targeted drug delivery and reduced systemic side effects. Despite experimental support, limited clinical studies validate their efficacy and safety. This narrative review explores the resurgence of interest in nebulized antibiotics, particularly in combating severe respiratory infections caused by emerging multidrug-resistant strains. Concord Biotech is dedicated to sharing the latest updates on advancements in intensive care. The Good Health Conquest podcast is available on all major listening platforms and apps. To read more about the article & subscribe to our podcast, log onto www.incacare.live.

    3 min

  7. 01/04/2024

    New Frontiers in Sepsis-Induced Acute Kidney Injury and Blood Purification Therapies

    Today, our focus is on Acute Kidney Injury (AKI), a prevalent consequence of sepsis that carries a staggering mortality rate of up to 40%. The pathogenesis of septic AKI is a complex interplay of mechanisms, culminating in an exacerbated inflammatory response and renal injury. Recent studies have highlighted the crucial role of the complement system activation as a mediator in AKI, shedding light on potential therapeutic avenues. Concord Biotech is dedicated to sharing the latest updates on advancements in intensive care. The Good Health Conquest podcast is available on all major listening platforms and apps. To read more about the article & subscribe to our podcast, log onto www.conquest.health.

    2 min

  8. 12/12/2023

    Understanding Non-Alcoholic Fatty Liver Disease: A Silent Threat

    In today’s episode of Good Health Conquest, let’s understand more about Non-Alcoholic Fatty Liver Disease. Non-alcoholic fatty liver disease (NAFLD) is the term for a range of conditions caused by a build-up of fat in the liver. Individuals with certain health conditions and diseases, such as obesity, metabolic syndrome, and type 2 diabetes, are at an increased risk of developing NAFLD.  In this podcast, we will navigate the complexities of Non-Alcoholic Fatty Liver Disease, its risk factors and effective management strategies. The Good Health Conquest podcast is available on all major listening platforms and apps. To read more about the article & subscribe to our podcast, log onto www.conquest.health.

    8 min
See All (35)

About

Concord Biotech is committed to helping raise awareness of Lupus, a long term illness that can leave a devastating impact on lives and livelihoods. This podcast series discusses the impact of Lupus with health practitioners, medical experts, caregivers and sufferers to understand how to actively manage this health condition.

Information

  • Creator
    Concord Biotech Ltd.
  • Years Active
    2021 - 2024
  • Episodes
    35
  • Rating
    Clean
  • Copyright
    © Concord Biotech Ltd.
  • Show Website
    The Good Health Conquest